Details

Autor(en) / Beteiligte

• Thomas, Merlin C.
• Brownlee, Michael
• Susztak, Katalin
• Sharma, Kumar
• Jandeleit-Dahm, Karin A. M.
• Zoungas, Sophia
• Rossing, Peter
• Groop, Per-Henrik
• Cooper, Mark E.

Titel

Diabetic kidney disease

Ist Teil von

• Nature reviews. Disease primers, 2015-07, Vol.1 (1), p.15018-15018, Article 15018

Ort / Verlag

London: Nature Publishing Group UK

Erscheinungsjahr

2015

Quelle

MEDLINE

Beschreibungen/Notizen

• The kidney is arguably the most important target of microvascular damage in diabetes. A substantial proportion of individuals with diabetes will develop kidney disease owing to their disease and/or other co-morbidity, including hypertension and ageing-related nephron loss. The presence and severity of chronic kidney disease (CKD) identify individuals who are at increased risk of adverse health outcomes and premature mortality. Consequently, preventing and managing CKD in patients with diabetes is now a key aim of their overall management. Intensive management of patients with diabetes includes controlling blood glucose levels and blood pressure as well as blockade of the renin–angiotensin–aldosterone system; these approaches will reduce the incidence of diabetic kidney disease and slow its progression. Indeed, the major decline in the incidence of diabetic kidney disease (DKD) over the past 30 years and improved patient prognosis are largely attributable to improved diabetes care. However, there remains an unmet need for innovative treatment strategies to prevent, arrest, treat and reverse DKD. In this Primer, we summarize what is now known about the molecular pathogenesis of CKD in patients with diabetes and the key pathways and targets implicated in its progression. In addition, we discuss the current evidence for the prevention and management of DKD as well as the many controversies. Finally, we explore the opportunities to develop new interventions through urgently needed investment in dedicated and focused research. For an illustrated summary of this Primer, visit: http://go.nature.com/NKHDzg Diabetic kidney disease is caused by microvascular damage sustained as a result of diabetes. Cooper et al . discuss current knowledge on this condition, arguing that novel strategies to halt and reverse disease progression are urgently needed.